The 2022 OncoAlert Colloquium Day 6: EONS Sessions
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
The 2022 OncoAlert Colloquium Day 5: GI Oncology
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
The 2022 OncoAlert Colloquium Day 2: GU Oncology
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
10 fundamental health literacy principles for the public to understand when reading health-related articles
The placebo effect in oncology trials and the criteria for approving drugs
Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients
T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1
ASH 2022: Multiple myeloma roundup
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML